The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries (2017)
- Authors:
- USP affiliated authors: COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; ABUMANSUR, JULIANA TRENCH - FMRP ; LAURETTI, GABRIELA ROCHA - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1007/s00228-017-2243-1
- Subjects: FARMACOGENÉTICA; FARMACOCINÉTICA; POLIMORFISMO; BLOQUEIO NERVOSO
- Keywords: Pharmacogenetics; Rocuronium; Neuromuscular blockade; SNPs; Pharmacokinetics
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Clinical Pharmacology
- ISSN: 0031-6970
- Volume/Número/Paginação/Ano: v. 73, n. 8, p. 957-963, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
COSTA, A. C. C. et al. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, v. 73, n. 8, p. 957-963, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00228-017-2243-1. Acesso em: 28 dez. 2025. -
APA
Costa, A. C. C., Coelho, E. B., Lanchote, V. L., Correia, B. V., Abumansur, J. T., Lauretti, G. R., & Moraes, N. V. de. (2017). The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, 73( 8), 957-963. doi:10.1007/s00228-017-2243-1 -
NLM
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1007/s00228-017-2243-1 -
Vancouver
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1007/s00228-017-2243-1 - Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain
- In vivo activity of CYP2D6 and enantioselective tramadol clearance in patients with neuropathic pain
- Analysis of rocuronium in human plasma by liquid chromatography–tandem mass spectrometry with application in clinical pharmacokinetics
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics
- Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers
- Stereoselective 'alfa'-hydroxylation of metoprolol in hypertensive patients with renal failure
- Stereospecific pharmacodymamics/pharmacokinetics of metoprolol in rats
- Effect of CYP inhibitors on the stereoselective kinetic disposition of metoprolol in rats
- Stereoselective determination of citalopram by liquid chromatography-tandem mass spectrometry in human plasma for pharmacokinetic
Informações sobre o DOI: 10.1007/s00228-017-2243-1 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002916789.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
